Considering using Emergency A meeting was also discussed along with the subject of the advance purchase commitment including the vaccine price in which NITI Aayog member (Health) Vinod Paul, Principal Scientific Advisor to the Government K Vijay Raghavan and Union Health Secretary Rajesh Bhushan participated . A source said, “It has been decided that the team constituted by the Prime Minister’s Office will set the principles of approving the use of vaccine task force (VTF) in an emergency. At the same time, the National Expert Group on Vaccine Administration for Kovid-19 should play a leading role in deciding the principles for advance market commitments, including the value of vaccines.
Pfizer company asked for permissionThe development came in the backdrop of the Pfizer company seeking the rights of emergency use of its Kovid-19 vaccine from US regulators. Another US biotechnology company, Moderna, said it too would apply for the right to emergency use to the US Food and Drug Administration (USFDA) in the coming weeks. Meanwhile, five vaccines in India are in various stages of clinical trials.
Serum third stage testThe Serum Institute of India is currently conducting Phase III trials of the Oxford-Astrogenica vaccine, while Bharat Biotech and ICMR have begun Phase III trials of indigenously developed covicin. The vaccine developed by Zydus Cadila has completed Phase II clinical trials in the country.
Sputnik will also start trialDr Reddy’s Laboratories will soon begin the second and third phase mass trials of Russian vaccine Sputnik-5 in India. According to the source, a meeting of the Vaccine Task Force (VTF) will be convened with experts to review the scientific status of vaccines worldwide and consider how and when a decision should be taken to authorize the emergency use of vaccines.